Blood Vessels-on-Chip to Understand and Target COVID-19

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 114025010

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $273,541.19
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    Pending
  • Research Location

    Netherlands
  • Lead Research Institution

    University of Twente
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Project description When COVID-19 patients become seriously ill, they often have problems in their blood vessels. This is how we see leakage, inflammation and blood clotting. In this project, a mini-blood vessel based on human vascular wall tissue and COVID-19 patient plasma is used to study blood clot formation. It is not yet clear why vascular problems occur in COVID-19 and whether they offer starting points for treatments. Finding answers to these questions is made difficult because laboratory animals infected with the SARS-CoV-2 virus do not develop complications in their blood vessels. It is therefore essential to perform this research using human tissues. In the project, researchers from the University of Twente will build and analyze the mini-blood vessels. Researchers from the Amsterdam UMC will collect and characterize the patient plasma for these models. Experts from the LUMC will perform molecular biological analysis on the cultured tissues.